- Home
- ELWS vs IBIO Comparison
ELWS vs IBIO Comparison
Compare ELWS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- IBIO
- Stock Information
- Founded
- ELWS 2018
- IBIO 2008
- Country
- ELWS Japan
- IBIO United States
- Employees
- ELWS N/A
- IBIO N/A
- Industry
- ELWS
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- IBIO Health Care
- Exchange
- ELWS Nasdaq
- IBIO Nasdaq
- Market Cap
- ELWS 12.1M
- IBIO 11.9M
- IPO Year
- ELWS 2023
- IBIO N/A
- Fundamental
- Price
- ELWS $2.29
- IBIO $0.88
- Analyst Decision
- ELWS
- IBIO Strong Buy
- Analyst Count
- ELWS 0
- IBIO 2
- Target Price
- ELWS N/A
- IBIO $5.50
- AVG Volume (30 Days)
- ELWS 71.7K
- IBIO 1.9M
- Earning Date
- ELWS 09-30-2025
- IBIO 11-11-2025
- Dividend Yield
- ELWS N/A
- IBIO N/A
- EPS Growth
- ELWS N/A
- IBIO N/A
- EPS
- ELWS N/A
- IBIO N/A
- Revenue
- ELWS $3,083,071.00
- IBIO $400,000.00
- Revenue This Year
- ELWS N/A
- IBIO N/A
- Revenue Next Year
- ELWS N/A
- IBIO N/A
- P/E Ratio
- ELWS N/A
- IBIO N/A
- Revenue Growth
- ELWS 145.52
- IBIO 77.78
- 52 Week Low
- ELWS $1.64
- IBIO $0.56
- 52 Week High
- ELWS $10.50
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- ELWS 43.50
- IBIO 56.65
- Support Level
- ELWS $2.14
- IBIO $0.83
- Resistance Level
- ELWS $2.47
- IBIO $0.97
- Average True Range (ATR)
- ELWS 0.21
- IBIO 0.06
- MACD
- ELWS 0.04
- IBIO -0.00
- Stochastic Oscillator
- ELWS 61.05
- IBIO 54.95
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.